The rise of Viagra initially fueled a period of growth for pharma, however recent developments present a complicated outlook for investors. Off-patent competitors are eroding revenue, and ongoing litigation add more https://ronaldpyfw589585.blog-a-story.com/22973660/viagra-and-pharma-a-risky-investment